Published in N Engl J Med on July 16, 2009
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation (2014) 3.04
Endoscopic venous harvesting by inexperienced operators compromises venous graft remodeling. Ann Thorac Surg (2011) 2.09
Impact of the learning curve for endoscopic vein harvest on conduit quality and early graft patency. Ann Thorac Surg (2011) 1.56
Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function. Am Surg (2011) 1.03
Evaluation of endoscopic vein extraction on structural and functional viability of saphenous vein endothelium. J Cardiothorac Surg (2011) 0.90
Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery. J Cardiovasc Surg (Torino) (2011) 0.87
Surgery: Open or endoscopic vein graft harvesting-this is the question! Nat Rev Cardiol (2009) 0.85
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg (2014) 0.85
Is endoscopic harvesting bad for saphenous vein graft patency in coronary surgery? Curr Opin Cardiol (2011) 0.84
Mid-term outcomes for Endoscopic versus Open Vein Harvest: a case control study. J Cardiothorac Surg (2010) 0.83
Endoscopic versus open vein-graft harvesting. N Engl J Med (2009) 0.83
Endoscopic vein harvesting: technique, outcomes, concerns & controversies. J Thorac Dis (2013) 0.83
Videoscope-assisted cardiac surgery. J Thorac Dis (2014) 0.82
The use of minimally invasive videoscopic technique in large vessel and cardiac surgery. Does the potentially increased difficulty bring benefits to the patient? Wideochir Inne Tech Maloinwazyjne (2012) 0.81
Development of viral vectors for use in cardiovascular gene therapy. Viruses (2010) 0.81
Conduits for Coronary Bypass: Arteries Other Than the Internal Thoracic Artery's. Korean J Thorac Cardiovasc Surg (2013) 0.80
Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? Am Heart J (2013) 0.79
Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein graft. Br J Pharmacol (2012) 0.79
Major themes for 2009 in cardiothoracic and vascular anesthesia. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.78
A randomized study comparing three groups of vein harvesting methods for coronary artery bypass grafting: endoscopic harvest versus standard bridging and open techniques. Interact Cardiovasc Thorac Surg (2012) 0.78
Early Outcomes of Endoscopic Vein Harvesting during the Initial Learning Period. Korean J Thorac Cardiovasc Surg (2015) 0.78
Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting. Biomed Res Int (2013) 0.77
Strategies for the coronary surgeon to remain "competitive and co-operative" in the PCI era. Indian Heart J (2015) 0.77
Conduits for coronary bypass: vein grafts. Korean J Thorac Cardiovasc Surg (2012) 0.76
Development of a flexible implantable sensor for postoperative monitoring of blood flow. J Ultrasound Med (2012) 0.76
Immunohistochemistry comparing endoscopic vein harvesting vs. open vein harvesting on saphenous vein endothelium. J Cardiothorac Surg (2014) 0.76
One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts. J Cardiothorac Surg (2015) 0.75
Endoscopic vein harvesting is influenced by patient-related risk factors and may be of specific benefit in female patients. Interact Cardiovasc Thorac Surg (2013) 0.75
Endoscopic versus open vein-graft harvesting. N Engl J Med (2009) 0.75
Endoscopic Saphenous harvesting with an Open CO2 System (ESOS) trial for coronary artery bypass grafting surgery: study protocol for a randomized controlled trial. Trials (2011) 0.75
Comparative results of endoscopic and open methods of vein harvesting for coronary artery bypass grafting: a prospective randomized parallel-group trial. J Cardiothorac Surg (2015) 0.75
Prevention of vessel desiccation and maintenance of normal morphology during endovascular harvesting using humidified warmed gas. JSLS (2012) 0.75
Endoscopic vein harvest in elective off-pump coronary artery bypass grafting. J Zhejiang Univ Sci B (2009) 0.75
Endoscopic versus open vein-graft harvesting. N Engl J Med (2009) 0.75
Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia. J Vasc Surg (2014) 0.75
NHS Evidence--promoting efficiency and quality through evidence-based decisions. Ann R Coll Surg Engl (2010) 0.75
Preoperative evaluation of the saphenous vein by 3-D contrastless computed tomography. Interact Cardiovasc Thorac Surg (2013) 0.75
Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". Circulation (2015) 0.75
Hybrid approach to multivessel coronary artery disease: a commentary. Ann Transl Med (2016) 0.75
Endoscopic or No-Touch Vein Harvesting for CABG: What is Best for the Patient? Braz J Cardiovasc Surg (2017) 0.75
Clinicopathological comparisons of open vein harvesting and endoscopic vein harvesting in coronary artery bypass grafting patients in Mashhad. Electron Physician (2016) 0.75
Endoscopic versus open vein-graft harvesting. N Engl J Med (2009) 0.75
A comprehensive review on learning curve associated problems in endoscopic vein harvesting and the requirement for a standardised training programme. J Cardiothorac Surg (2016) 0.75
Endoscopic vein harvesting for coronary bypass grafting: a blessing or a trojan horse? Cardiol Res Pract (2011) 0.75
Prospective comparative study of single-layer versus double-layer closure of leg wounds after long saphenous vein harvest in coronary artery bypass graft operations. J Thorac Dis (2011) 0.75
Almanac 2013: stable coronary artery disease. Wien Klin Wochenschr (2013) 0.75
Angiotensin II, as well as 5-hydroxytriptamine, is a potent vasospasm inducer of saphenous vein graft for coronary artery bypass grafting in patients with diabetes mellitus. Biochem Biophys Rep (2016) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Universal definition of myocardial infarction. Circulation (2007) 11.69
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
The ClinicalTrials.gov results database--update and key issues. N Engl J Med (2011) 9.83
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (2005) 5.28
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
What clinicians should know about the QT interval. JAMA (2003) 4.45
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med (2013) 4.16
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA (2011) 3.97
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83